John Docherty
Fortuna: 33 293 $ al 30/06/2026
Fortuna: 33 293 $ al 30/06/2026
John Martin Docherty is currently President, Chief Scientific Officer & Director at Lexaria Bioscience Corp.
since 2015.
Formerly, Mr. Docherty was President & Director at PharmaDerm Laboratories Ltd. from 2004 to 2008 and President & Chief Operating Officer at Helix BioPharma Corp.
from 2007 to 2013.
Education includes undergraduate and graduate degrees from the University of Toronto, conferred in 1993 and 1995 respectively.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LEXARIA BIOSCIENCE CORP. 0,24 % | 01/12/2025 | 59.451 ( 0,24 % ) | 33 293 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | Presidente | 15/04/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
| HELIX BIOPHARMA CORP. | Presidente | 01/12/2013 |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. | Presidente | 01/07/2008 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Helix BioPharma Corp.
Helix BioPharma Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention and treatment of cancer | Health Technology |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp. Pharmaceuticals: MajorHealth Technology Engages in drug delivery technology | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaDerm Laboratories Ltd.
PharmaDerm Laboratories Ltd. Part of Helix BioPharma Corp., PharmaDerm Laboratories Ltd. is a pharmaceutical company based in Saskatoon, Canada. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.